28/05 Physiomics Demonstrates Hantavirus Translational Modelling Capability CI
27/05 Physiomics Secures Contracts from UK, International Clients MT
27/05 Physiomics plc Receives Multiple New Contracts CI
15/05 Physiomics CEO Extends Contract Through June MT
15/05 Physiomics says Peter Sargent to remain CEO of co through June 2026 RE
08/05 Physiomics Kicks off Business Review for Operational Optimization MT
08/05 Physiomics Plc Initiates Strategic Review to Enhance Long-Term Shareholder Value CI
08/05 Physiomics implements disciplined capital allocation and strict cost control measures RE
30/04 Declaration of Voting Results by Physiomics CI
30/04 Physiomics stock rises as shareholders vote to oust board AN
29/04 Physiomics plc Announces Board Changes, Effective April 29, 2026 CI
25/04 Physiomics Reminds Shareholders to Vote Against Mike Whitlow CI
24/04 Physiomics board recommends voting against all resolutions at 29 April general meeting RE
17/04 ISS Recommends Against Proposed Replacement of Physiomics Board MT
17/04 Physiomics says ISS recommends vote against board removal resolutions RE
14/04 Physiomics plc Announces That It Has Entered into A New Contract with Numab Therapeutics AG CI
14/04 Physiomics Bags Contract to Support Numab's New Oncology Project MT
10/04 Physiomics Plc - Special Call
08/04 Physiomics Board Urges Shareholders to Reject 'Premature, Potentially Disruptive' Proposal to Replace Directors MT
08/04 Physiomics expects total income to increase 27% for FY ending June 2026 RE
08/04 Physiomics plc Provides Total Income Guidance for the Financial Year Ending June 2026 CI
03/04 Physiomics : Notice of General Meeting 29th April 2026 PU
03/04 Physiomics Issues Recommendations to Shareholders CI
20/03 Physiomics Cancels General Meeting Set on April 7 MT
19/03 Physiomics Completes Fundraise for Business Investments, Software Development MT
No results match your criteria
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!